EXELIXIS, INC. — Director's Dealing 2018

Nov 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2018-11-15

Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-15	Common Stock	F	9916	$17.45	Disposed	115084	Direct
2018-11-15	Common Stock	F	7437	$17.45	Disposed	107647	Direct
2018-11-15	Common Stock	M	25000	$4.42	Acquired	132647	Direct
2018-11-15	Common Stock	S	25000	$17.22	Disposed	107647	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-15	Option (right to buy)	$4.42	M	25000	Disposed	2019-02-25	Common Stock (25000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	176351	Indirect
Common Stock	17354	Indirect

Footnotes

F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017.

F2: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F3: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 26, 2016.

F4: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.16 to $17.30. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.

F5: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.

F6: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 14, 2018.

F7: The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 26, 2013.